Emulsion-free chitosan-genipin microgels for growth plate cartilage regeneration.
Chitosan
cartilage regeneration
growth plate
injectable biomaterials
microgels
Journal
Journal of biomaterials applications
ISSN: 1530-8022
Titre abrégé: J Biomater Appl
Pays: England
ID NLM: 8813912
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
pubmed:
13
3
2021
medline:
4
2
2022
entrez:
12
3
2021
Statut:
ppublish
Résumé
The growth plate is a cartilage tissue near the ends of children's long bones and is responsible for bone growth. Injury to the growth plate can result in the formation of a 'bony bar' which can span the growth plate and result in bone growth abnormalities in children. Biomaterials such as chitosan microgels could be a potential treatment for growth plate injuries due to their chondrogenic properties, which can be enhanced through loading with biologics. They are commonly fabricated via an emulsion method, which involves solvent rinses that are cytotoxic. Here, we present a high throughput, non-cytotoxic, non-emulsion-based method to fabricate chitosan-genipin microgels. Chitosan was crosslinked with genipin to form a hydrogel network, and then pressed through a syringe filter using mesh with various pore sizes to produce a range of microgel particle sizes. The microgels were then loaded with chemokines and growth factors and their release was studied in vitro. To assess the applicability of the microgels for growth plate cartilage regeneration, they were injected into a rat growth plate injury. They led to increased cartilage repair tissue and were fully degraded by 28 days in vivo. This work demonstrates that chitosan microgels can be fabricated without solvent rinses and demonstrates their potential for the treatment of growth plate injuries.
Identifiants
pubmed: 33709832
doi: 10.1177/0885328221999894
pmc: PMC8319035
mid: NIHMS1682922
doi:
Substances chimiques
Biocompatible Materials
0
Emulsions
0
Iridoids
0
Microgels
0
Chitosan
9012-76-4
genipin
A3V2NE52YG
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
289-296Subventions
Organisme : NIAMS NIH HHS
ID : R03 AR068087
Pays : United States
Organisme : NIAMS NIH HHS
ID : R21 AR071585
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001081
Pays : United States
Références
J Biomed Mater Res B Appl Biomater. 2020 Aug;108(6):2484-2494
pubmed: 32034881
Carbohydr Polym. 2018 Sep 15;196:233-245
pubmed: 29891292
J Bone Miner Res. 2016 Jun;31(6):1258-74
pubmed: 26763079
Biomed Mater. 2020 May 05;15(4):045003
pubmed: 31530754
Bone. 2010 Dec;47(6):1076-9
pubmed: 20817052
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6941-6
pubmed: 9618518
Bioact Mater. 2020 Feb 12;5(1):164-183
pubmed: 32083230
J Biol Chem. 2017 Apr 28;292(17):7173-7188
pubmed: 28228478
J Orthop Res. 2004 Mar;22(2):417-26
pubmed: 15013105
J Vis Exp. 2017 Jul 4;(125):
pubmed: 28715376
Int J Biol Macromol. 2017 Nov;104(Pt B):1936-1945
pubmed: 28359897
Tissue Eng. 2005 Jan-Feb;11(1-2):130-40
pubmed: 15738668
Carbohydr Polym. 2014 Oct 13;111:348-55
pubmed: 25037360
Biomacromolecules. 2008 Oct;9(10):2764-74
pubmed: 18816100
Carbohydr Polym. 2016 Nov 5;152:792-801
pubmed: 27516331
J Biomed Mater Res A. 2010 Nov;95(2):465-75
pubmed: 20648541
Mar Drugs. 2015 Dec 11;13(12):7314-38
pubmed: 26690453
J Endocrinol. 2014 Mar 07;221(1):63-75
pubmed: 24464023
Drug Dev Ind Pharm. 1998 Nov;24(11):979-93
pubmed: 9876553
Tissue Eng Part B Rev. 2018 Apr;24(2):85-97
pubmed: 28830302
J Biomed Mater Res A. 2016 Aug;104(8):1863-70
pubmed: 27027247
Biomed Mater Eng. 2017;28(s1):S209-S215
pubmed: 28372297
J Biomed Mater Res B Appl Biomater. 2004 Nov 15;71(2):373-80
pubmed: 15386401
J Orthop Res. 2020 Nov 12;:
pubmed: 33179297